OncoImmunology (O) is a scholarly journal dedicated to publishing research in the field of Medicine. Taylor and Francis is the publisher of this esteemed journal.
The P-ISSN assigned to OncoImmunology is 2162-4011 and its abbreviated form is Oncoimmunology.
OncoImmunology is a dynamic, high-profile, open access journal broadly covering tumor immunology and immunotherapy.
As cancer immunotherapy continues to evolve, OncoImmunology aims to publish high-quality, rigorous research on all aspects of basic and applied tumor immunology.
Topics covered include:
Basic and translational studies in immunology of both solid and hematological malignancies
Inflammation, innate and acquired immune responses against cancer
Mechanisms of cancer immunoediting and immune evasion
Modern immunotherapies including, but not limited to, immunomodulators, immune checkpoint inhibitors, T-cell, NK-cell and macrophage engagers, and CAR T cells
Immunological effects of conventional anticancer therapies.
The journal publishes original research articles, brief reports, reviews, trial watches, commentaries, and meeting reports. Please note that trial watches are solicted by the Editors on an invitation-only basis.
Abbreviation :ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of OncoImmunology Journal is Oncoimmunology.
The Ranking of the Journal in 2024 is 1315. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 7.2. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 2.003. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 103. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is Research articles £2495GBP, $3175USD, €2895EUR, Brief Reports $2070 USD, £1625GBP, €1885EUR
No, the journal is not indexed in Index copernicus.
is a predatory journal?
No, journal is not a predatory journal.
What is the Imptact Factor of OncoImmunology?
The Impact Factor of the Journal is 7.2.
What is the Ranking of the Journal?
The Ranking of the Journal is 1315.
is journal peer reviewed?
Yes the journal is a peer-reviewed journal.
is OncoImmunology a good journal?
Yes the journal is a peer-reviewed journal and good to publish your paper.
What is OncoImmunology?
OncoImmunology (O) is a scholarly journal dedicated to publishing research in the field of Medicine. Taylor and Francis is the publisher of this esteemed journal.